Common Contracts
5 similar Underwriting Agreement contracts by Argos Therapeutics Inc, Gelesis Inc, Orthopediatrics Corp, others
●] Shares SUPER LEAGUE GAMING, INC. Common Stock, par value $0.001 per share UNDERWRITING AGREEMENTUnderwriting Agreement • February 12th, 2019 • Super League Gaming, Inc. • Services-amusement & recreation services • New York
Shares OrthoPediatrics Corp. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • October 2nd, 2017 • Orthopediatrics Corp • Surgical & medical instruments & apparatus • New York
9,090,909 Shares of Common Stock and Warrants to Purchase 6,818,181 Shares of Common Stock Argos Therapeutics, Inc. UNDERWRITING AGREEMENTUnderwriting Agreement • July 29th, 2016 • Argos Therapeutics Inc • Pharmaceutical preparations • New York
Argos Therapeutics, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of (i) 9,090,909 shares (each, a “Share”) of the Company’s Common Stock, $0.001 par value per share (the “Common Stock”) and (ii) warrants to purchase up to 6,818,181 shares of Common Stock in the form set forth in Exhibit A (each, a “Warrant”). Each Share is being sold together with a Warrant to purchase 0.75 of a share of Common Stock at an exercise price of $5.50 per whole share of Common Stock. The Shares and Warrants are collectively called the “Securities.” The shares of Common Stock underlying the Warrants are called the “Warrant Shares.”
— ] Shares Gelesis, Inc. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • April 23rd, 2015 • Gelesis Inc • Pharmaceutical preparations • New York
Gelesis, Inc. (the “Company”) announced today that Piper Jaffray & Co. and Stifel, Nicolaus & Company, Incorporated, as the representatives of the underwriters, are [waiving] [releasing] [a] lock-up restriction[s] with respect to an aggregate of **[# of common shares] held by certain [officers] [directors] of the Company. These [officers] [directors] entered into lock-up agreements with the representatives in connection with the Company’s initial public offering.
—] Shares Pfenex Inc. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • July 7th, 2014 • Pfenex Inc. • Pharmaceutical preparations • New York
Pfenex Inc., a Delaware corporation (the “Company”), proposes to sell to the several Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of [—] shares (the “Firm Shares”) of Common Stock, $0.001 par value per share (the “Common Stock”), of the Company. The Company has also granted to the several Underwriters an option to purchase up to [—] additional shares of Common Stock on the terms and for the purposes set forth in Section 3 hereof (the “Option Shares”). The Firm Shares and any Option Shares purchased pursuant to this Underwriting Agreement are herein collectively called the “Securities.”
